Invited Speakers
Invited speakers for the joint session on 9 April
Mathematical modeling of kinetics and resistance in the development of antiviral drugs
Dr. A. Neumann
Treatment strategies for HIV/hepatitis virus co infected patients: considerations related to pharmacology and drug resistance
Dr. D. Thomas
New paradigms in antiviral drug development
Dr. K. Reynolds & Dr. K. Struble
Understanding drug-related hepatotoxicity
Dr. P. Watkins
Invited Speakers for the workshop on 10 April
Epidemiology of hepatitis in the developing world
Dr. D. Thomas
Special challenges in drug development
Dr. T. Blaschke
Considerations in worldwide clinical trials
Dr. L. McNair
Necessary adaptations in pharmacodynamic modeling of two therapeutic targets in Hepatitis
Dr. A. Neuman
Liver targeting, transporters and drug uptake
Dr. R. Kim
